AVI Biopharma, Inc. (AVII) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts AVII Hot Sheet
Price: $0.66 --0%
Financial Fact:
Net income (loss) and comprehensive income (loss): -56.74M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net income (loss) and comprehensive income (loss): -56.74M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
AVI Biopharma, Inc. (NASDAQ: AVII) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $15.5 million versus the consensus estimate of $11.65 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
- Paramount Global (PARA) Tops Q2 EPS by 480c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
